SELLAS Life Sciences (SLS) Cash from Discontinued Operations (2014 - 2017)

SELLAS Life Sciences (SLS) has 4 years of Cash from Discontinued Operations data on file, last reported at 2449000.0 in Q3 2017.

• On a quarterly basis, Cash from Discontinued Operations fell 20.28% year-over-year to 2449000.0 in Q3 2017; TTM through Sep 2017 was 12467000.0, a 7.42% increase from a year earlier, with the FY2016 full-year figure at 11685000.0, down 24.87% from the prior year.
• Cash from Discontinued Operations for Q3 2017 stood at 2449000.0, up from 2484000.0 in the prior quarter.
• Over the last five years, Cash from Discontinued Operations for SLS reached as high as 1059000.0 in Q1 2015 and fell as low as 5004000.0 in Q1 2017.
• Historically, Cash from Discontinued Operations has averaged 2785000.0 across 4 years, with a median of 2507000.0 in 2016.
• On a YoY basis, Cash from Discontinued Operations climbed as much as 41.31% in 2016 and fell as far as 228.14% in 2016.
• Year by year, Cash from Discontinued Operations stood at 2440000.0 in 2014, then sank by 76.68% to 4311000.0 in 2015, then soared by 41.31% to 2530000.0 in 2016, then increased by 3.2% to 2449000.0 in 2017.
• Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 2449000.0 in Q3 2017, 2484000.0 in Q2 2017, and 5004000.0 in Q1 2017.